Life Sciences Licensing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Licensing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Licensing Today - Breaking & Trending Today

Ropes & Gray Advises Everest Medicines on Agreement with Gilead Sciences for Cancer Drug Trodelvy in Asia Territories

Published: August 17, 2022

Everest Medicines, advised by Ropes & Gray, announced on Aug. 16, 2022, that it has entered into an agreement with Immunomedics, Inc. under which Immunomedics will obtain exclusive rights to develop and commercialize cancer drug Trodelvy in Asia territories.

Source: ropesgray.com

Related Topics:

Hong KongUnited StatesRepublic OfSouth KoreaAsia PacificImmunomedics IncChina Life SciencesGilead SciencesLife Sciences LicensingGilead Sciences For Cancer Drug TrodelvyGray Advises Everest MedicinesCancer Drug TrodelvyAsia TerritoriesStrategic Licensing ProgramsJoint VenturesStrategic Commercial